Filing Flows › Stemtech (STEK) › Q1 2026 › vs Q1 2025
Stemtech (STEK) Q1 2026 vs Q1 2025 (year over year)
Stemtech's revenue fell $405K (-47%) from $868K in Q1 2025 to $463K in Q1 2026.
Stemtech, Q1 2026: revenue $463K (-47% year over year), operating margin -236.4%, net loss $1.3M, operating cash flow −$426K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $463K | $868K | −$405K | -47% |
| Net loss | $1.3M | $1.5M | −$206K | -14% |
| Costs & expenses | $1.7M | $2.3M | −$611K | -26% |
| Operating costs | $1.6M | $2.1M | −$516K | -25% |
| Interest & other, net | $159K | $254K | −$95K | -38% |
| Cost of revenue | $109K | $148K | −$38K | -26% |
| General & admin | $1.4M | $1.7M | −$328K | -19% |
| Other operating costs | $49K | $198K | −$149K | -75% |
| Operating cash sources | $1.3M | $1.5M | −$206K | -14% |
| Depreciation & amortization | $42K | $42K | −$3 | 0% |
| Share-based compensation | $108K | $108K | $0 | 0% |
| Working capital & other | $677K | $598K | $79K | +13% |
| Cash used in operations | $426K | $711K | −$285K | -40% |
| Net loss absorbed | $1.3M | $1.5M | −$206K | -14% |
Questions
How much did Stemtech's revenue grow year over year in Q1 2026?
Stemtech's revenue fell $405K (-47%) from $868K in Q1 2025 to $463K in Q1 2026.